Gremlin 1 Expression Distinguishes Stem Cells Able to Regenerate Bones and Cartilage in Adult Mice
By LabMedica International staff writers Posted on 26 Jan 2015 |
Image: The osteochondroretricular stem cell is a newly identified type of bone stem cell that appears to be vital to skeletal development and may provide the basis for novel treatments for osteoarthritis, osteoporosis, and bone fractures. In this illustration of the head of a femur, osteochondroretricular stem cells are visualized in red (Photo courtesy of Dr. Timothy Wang, Columbia University).
A newly identified type of stem cell in the bone marrow of adult mice was found to be capable of regenerating both bone and cartilage.
Investigators at Columbia University (New York, NY, USA) reported in the January 15, 2015, online edition of the journal Cell that expression of the bone morphogenetic protein (BMP) antagonist gremlin 1 defined a population of osteochondroreticular (OCR) stem cells in the bone marrow.
BMPs are considered to constitute a group of pivotal morphogenetic signals, orchestrating tissue architecture throughout the body. Deletion of gremlin 1 in mice caused increased bone formation and increased trabecular bone volume, whereas overexpression caused inhibition of bone formation and osteopenia.
The investigators found that OCR stem cells self-renewed and generated osteoblasts, chondrocytes, and reticular marrow stromal cells, but not adipocytes. OCR stem cells were concentrated within the metaphysis of long bones not in the perisinusoidal space and were needed for bone development, bone remodeling, and fracture repair. Gremlin 1 expression also identified intestinal reticular stem cells (iRSCs) that are cells of origin for the periepithelial intestinal mesenchymal sheath. Thus, gremlin 1 expression identified distinct connective tissue stem cells in both the bone (OCR stem cells) and the intestine (iRSCs).
"Our findings raise the possibility that drugs or other therapies can be developed to stimulate the production of OCR stem cells and improve the body's ability to repair bone injury—a process that declines significantly in old age," said senior author Dr. Timothy C. Wang, professor of medicine at Columbia University.
Related Links:
Columbia University
Investigators at Columbia University (New York, NY, USA) reported in the January 15, 2015, online edition of the journal Cell that expression of the bone morphogenetic protein (BMP) antagonist gremlin 1 defined a population of osteochondroreticular (OCR) stem cells in the bone marrow.
BMPs are considered to constitute a group of pivotal morphogenetic signals, orchestrating tissue architecture throughout the body. Deletion of gremlin 1 in mice caused increased bone formation and increased trabecular bone volume, whereas overexpression caused inhibition of bone formation and osteopenia.
The investigators found that OCR stem cells self-renewed and generated osteoblasts, chondrocytes, and reticular marrow stromal cells, but not adipocytes. OCR stem cells were concentrated within the metaphysis of long bones not in the perisinusoidal space and were needed for bone development, bone remodeling, and fracture repair. Gremlin 1 expression also identified intestinal reticular stem cells (iRSCs) that are cells of origin for the periepithelial intestinal mesenchymal sheath. Thus, gremlin 1 expression identified distinct connective tissue stem cells in both the bone (OCR stem cells) and the intestine (iRSCs).
"Our findings raise the possibility that drugs or other therapies can be developed to stimulate the production of OCR stem cells and improve the body's ability to repair bone injury—a process that declines significantly in old age," said senior author Dr. Timothy C. Wang, professor of medicine at Columbia University.
Related Links:
Columbia University
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples